Does carbamazepine (an anticonvulsant medication) affect fertility in men and women?

Carbamazepine and Fertility

Direct Answer

Carbamazepine can impair fertility in both men and women through different mechanisms, but the effects are generally reversible and do not increase the risk of birth defects in offspring when conception occurs during treatment.

---

Effects on Female Fertility

Hormonal and Menstrual Disruption

Carbamazepine causes menstrual disturbances in approximately 25% of women through enzyme induction, resulting in low estradiol levels and reduced bioavailable sex hormones. 1

• Carbamazepine induces hepatic cytochrome P450-dependent steroid hormone breakdown and increases sex hormone binding globulin (SHBG) production, thereby reducing biologically active sex hormone concentrations 1
• This enzyme induction leads to a low estradiol/SHBG ratio, which manifests as menstrual irregularities 1
• Women with epilepsy on carbamazepine may experience earlier menopause compared to the general population 1

Weight Gain and Metabolic Effects

• Carbamazepine can cause weight gain, which reduces insulin sensitivity and may trigger polycystic ovary syndrome (PCOS) development in predisposed women 1
• Weight increase from antiepileptic drugs indirectly affects fertility through metabolic dysfunction 1

Contraceptive Interactions

• Carbamazepine renders hormonal contraceptives less effective by decreasing plasma hormone concentrations, leading to breakthrough bleeding and unintended pregnancies 2
• Alternative or backup contraception methods should be used when taking carbamazepine 2

---

Effects on Male Fertility

Sperm Parameter Abnormalities

Despite documented adverse effects on sperm parameters, current evidence shows no increased risk of birth defects or adverse pregnancy outcomes when men father children while taking carbamazepine. 3

• The FDA label reports rare cases of impaired male fertility and/or abnormal spermatogenesis in humans 2
• Animal studies demonstrate testicular atrophy in rats receiving carbamazepine at doses of 50-400 mg/kg/day for 4-52 weeks, with dose-related testicular atrophy and aspermatogenesis at 25-250 mg/kg/day for 2 years 2

Clinical Evidence of Reversible Effects

• A case report documented complete asthenozoospermia (no motile sperm) in a patient taking 400 mg/day carbamazepine for 13 years, with sperm motility improving to 65% one month after switching to phenytoin, followed by successful conception 5 months later 4
• Carbamazepine reduces sperm motility, increases abnormal sperm morphology, and impairs hormonal balance 5
• Molecular studies show carbamazepine alters testicular KCNJ11/miR-let-7a and spermatozoal CFTR/miR-27a expressions, correlating with decreased sperm motility and elevated sperm tail defects 5

Developmental Timing Matters

• Exposure during pre-puberty and puberty causes more severe damage than adult exposure, with effects on testicular development, spermatogenesis, and seminiferous epithelium damage persisting into adulthood 6, 7
• Maternal carbamazepine exposure during pregnancy impairs testicular development and spermatogenesis in male offspring at puberty 6

---

Clinical Management Algorithm

For Women of Reproductive Age

1. Counsel about menstrual irregularities and reduced fertility potential despite possible continuation of regular menses 1
2. Recommend non-hormonal contraception or backup methods due to enzyme induction reducing contraceptive efficacy 2
3. Monitor for weight gain and metabolic changes that may trigger PCOS development 1
4. Consider switching to non-enzyme-inducing antiepileptic drugs if fertility is a priority and seizure control permits 1

For Men Trying to Conceive

1. Reassure that offspring outcomes are not adversely affected by paternal carbamazepine exposure 3
2. Obtain semen analysis if conception has not occurred after 12 months of attempting 3
3. Do not discontinue carbamazepine solely for theoretical fertility concerns if seizures are well-controlled, as seizure recurrence risk outweighs reversible sperm changes 3
4. Consider assisted reproductive technologies (ART) if sperm abnormalities are documented rather than medication changes that could compromise seizure control 3
5. If medication change is necessary, monitor for improvement in sperm parameters 1-3 months after switching, as effects appear reversible 4

---

Critical Caveats

Pregnancy Considerations

• Carbamazepine is teratogenic and associated with congenital malformations including spina bifida, craniofacial defects, and cardiovascular malformations when used during pregnancy 2
• Women should enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry by calling 1-888-233-2334 2
• Monotherapy is preferable to combination therapy in pregnant women to reduce teratogenic risk 2

Epilepsy Itself Affects Fertility

• The underlying epilepsy, particularly temporal lobe epilepsy, independently contributes to reproductive dysfunction through effects on the hypothalamic-pituitary axis 1, 3
• Polycystic ovary syndrome occurs in 10-25% of women with temporal lobe epilepsy even without antiepileptic drug treatment 1
• Hypothalamic amenorrhea affects 12% of women with temporal lobe epilepsy versus 1.5% of the general population 1

Distinguishing Drug Effects from Disease Effects

• Separating carbamazepine effects from epilepsy-related reproductive dysfunction is challenging in clinical practice 1
• Postictal and interictal epileptic activity can cause functional hyperprolactinemia, leading to menstrual irregularities and subfertility independent of medication 1